We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Mylan Acquires King For $4B In Move Toward Branded Drugs

Law360 (July 26, 2004, 12:00 AM EDT) -- Mylan Laboratories, the largest maker of generic drugs in the U.S., has agreed to acquire competitor King Pharmaceuticals for about $4 billion in a move widely seen as a part of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.